Skip to main content
Blood Cancer Journal logoLink to Blood Cancer Journal
. 2023 Apr 13;13(1):52. doi: 10.1038/s41408-023-00825-7

Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

Jiahua Niu 1,2,#, Huiying Qiu 1,2,#, Fang Xiang 3,#, Lin Zhu 3, Jun Yang 1,2, Chongmei Huang 1,2, Kun Zhou 1,2, Yin Tong 1,2, Yu Cai 1,2, Baoxia Dong 1,2, Yuan Lu 3, Xuedong Sun 3, Liping Wan 1,2, Xueying Ding 2,, Haopeng Wang 4,, Xianmin Song 1,2,
PMCID: PMC10101942  PMID: 37055395

Correction to: Blood Cancer Journal 10.1038/s41408-023-00813-x, published online 24 March 2023

In the fifth line of the second paragraph, the word of “negative” in “MRD-negative complete remission” should be “positive”.

The original article has been corrected.

Contributor Information

Xueying Ding, Email: dingxueying@126.com.

Haopeng Wang, Email: wanghp@shanghaitech.edu.cn.

Xianmin Song, Email: shongxm@sjtu.edu.cn.


Articles from Blood Cancer Journal are provided here courtesy of Nature Publishing Group

RESOURCES